Abstract
It is thought that dysregulation of E-cadherin, syndecan-1 (CD138) and Ets-1 is involved in carcinoma development. E-cadherin is an important epithelial cell adhesion molecule; syndecan-1 (CD138) is a regulatory proteoglycan in both cell-cell and cell-matrix adhesion and Ets-1 is a proto-oncogene and transcription factor, which takes part in extracellular matrix remodeling. Our goal was to study the changes in the expression of these molecules during colon carcinoma development and progression. We tested 117 colon adenomas and 149 de novo and ex adenoma carcinomas of the colon, using the Ultravision Polymer system. The positive reaction rate was 100% for E-cadherin, 98.3% for syndecan-1 and 22.4% for Ets-1 in adenomas, while in carcinomas it was 88.5%, 62.4% and 56.3% respectively. We found decreasing expression of E-cadherin and syndecan-1 throughout colon carcinoma progression and an opposite regulation for the Ets-1 protein. Decrease in expression of syndecan-1 is more pronounced in carcinomas compared to E-cadherin. De novo carcinomas have lower E-cadherin and syndecan-1 expression, and higher Ets-1 expression compared to ex adenoma carcinomas. These findings support the hypothesis that there are differences in the carcinogenesis of these tumors.
Similar content being viewed by others
References
Vãlean S, Mircea PA, Oprea L (2006) Trends of mortality rates from gastric cancer and colorectal cancer in Romania, 1955–2003. J Gastrointestin Liver Dis 15(2):111–115
Hamilton RS, Aaltonen AL (2000) Pathology and genetics, toumors of the digestive system. IARC Press, Lyon
Pećina-Šlaus N (2003) Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int 3:17
Day MR, Hao X, Mohammad I, Daszak P, Talbot IC, Forbes A (1999) Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Arch 434:121–125
Beauvais DM, Rapraeger CA (2004) Syndecans in tumor cell adhesion and signaling. RB&E 2:3 http://www.rbej.com/content/2/1/3
Nakayama T, Masahiro I, Akira O, Shinji N, Ichiro S (2001) Expression of the ets-1 Proto-Oncogene in human colorectal carcinoma. Mod Pathol 14(5):415–422
Arun S, Watson KD (2005) Ets transcription factors and their emerging roles in human cancer. Eur J Cancer 41:2462–2478
Nosho K, Yoshiday M, Yamamoto M, Taniguchi H, Adachi Y, Mikami M, Hinodal Y, Imai K (2005) Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. Carcinogenesis 26(5):892–899
Behrens P, Mathiak M, Mangold E, Kirdorf S, Wellmann A, Fogt F, Rothe M, Florin A, Wernert N (2003) Stromal expression of invasion-promoting matrix-degrading proteases MMP-1 and -9 and the Ets-1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. Int J Cancer 107:183–188
Khoursheed MA, Mathew TC, Makar RR, Louis S, Asfar SK, Al-Sayer HM, Dashti HM, Al-Bader A (2003) Expression of E-cadherin in human colorectal cancer. Surg J R Coll Surg Edinb Irel 86–91
Elzagheid A, Ålgars A, Bendardaf R, Lamlum H, Ristamaki R, Collan Y, Syrjanen K, Pyrhonen S (2006) E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol 12(27):4304–4309
Fujiya M, Watari J, Ashida T, Honda M, Tanabe H, Fujiki T, Saitoh Y, Kohgo Y (2001) Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn. J Cancer Res 192:1074–1081
Lundin M, Nordling S, Lundin J, Isola J, Wiksten JP, Haglund C (2005) Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer. Oncology 68:306–313
Rosai J (2004) Rosai and Ackerman`s surgical pathology, 9th edn. Mosby, London
Geller SA, Dhall D, Alsabeh R (2008) Application of immunohistochemistry to liver and gastrointestinal neoplasms: liver, stomach, colon, and pancreas. Arch Pathol Lab Med 132:490–499
Wlodarczyk J, Bethke B, Mueller E, Stolte M, Mueller J (2001) A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum. Virchows Arch 439:756–761
Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K (2006) Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virchows Arch 448:763–767
Peretti T, Waisberg J, Mader AM, Matos L, Costa R, Conceicao G, Lopes A, Nader H, Pinhal M (2008) Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma. Eur J Gastroenterol & Hepatol 20:756–765
Gottardi JC, Wong E, Gumbiner MB (2001) E-Cadherin suppresses cellular transformation by inhibiting β-catenin signaling in an adhesion-independent manner. J Cell Biol 153(5):1049–1059
Qinglang L, Pyong WP, Wilson LC, Parks CW (2002) Matrilysin shedding of syndecan-1 regulates Chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635–646
Fitzgerald LM, Wang Z, Park WP, Murphy G, Bernfield M (2000) Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol 148(4):811–824
Hashimoto Y, Skacel M, Adams JC (2008) Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors. BMC Cancer 8(185):1–7
Kwak JM, Min BW, Lee JH, Choi JS, Lee SI, Park SS, Kim J, Um JW, Kim SH, Moon HY (2007) The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer. Dis Colon Rectum 50:1873–1880
Dilek F, Topak N, Aktepe F, Sahin O, Turel KS, Sahin DA, Dilek ON (2008) E-cadherin, β-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers. Pathol Res Practice 204(11):809–815
Tetsuji T, Koji M, Tsuyoshi H (2006) Colorectal cancer: genetics of development and metastasis. J Gastroenterology 41:185–192
Ortega P, Moran A, de Juan C, Frias C, Hernandez S, Lopez-Asenjo J-A, Sanchez-Pernaute A, Torres A, Iniesta P, Benito M (2008) Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability. Clin Cancer Res 14(4):995–1001
Jürgen D (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2:29 http://www.molecular-cancer.com/content/2/1/29
McGuire KJ, Qinglang L, Parks CW (2003) Matrilysin (Matrix Metalloproteinase-7) mediates E-Cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 162(6):1831–1843
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pap, Z., Pávai, Z., Dénes, L. et al. An Immunohistochemical Study of Colon Adenomas and Carcinomas: E-cadherin, Syndecan-1, Ets-1. Pathol. Oncol. Res. 15, 579–587 (2009). https://doi.org/10.1007/s12253-009-9157-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-009-9157-x